Stacey M. Anderson

5.6k total citations · 1 hit paper
49 papers, 2.6k citations indexed

About

Stacey M. Anderson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Stacey M. Anderson has authored 49 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 17 papers in Genetics. Recurrent topics in Stacey M. Anderson's work include Diabetes Management and Research (30 papers), Pancreatic function and diabetes (22 papers) and Diabetes and associated disorders (16 papers). Stacey M. Anderson is often cited by papers focused on Diabetes Management and Research (30 papers), Pancreatic function and diabetes (22 papers) and Diabetes and associated disorders (16 papers). Stacey M. Anderson collaborates with scholars based in United States, Italy and Germany. Stacey M. Anderson's co-authors include Boris Kovatchev, William L. Clarke, Marc D. Breton, Johannes D. Veldhuis, Stephen D. Patek, Lutz Heinemann, William S. Evans, Bruce A. Buckingham, James T. Patrie and Claudio Cobelli and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Stacey M. Anderson

48 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

2017 415 citations Bruce A. Buckingham, Stacey M. Anderson et al. Diabetes Technology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stacey M. Anderson United States	27	2.3k	1.4k	1.2k	303	257	49	2.6k
Kevin C.J. Yuen United States	31	2.3k 1.0×	639 0.5×	562 0.5×	75 0.2×	484 1.9×	147	3.1k
Leon S. Farhy United States	20	749 0.3×	355 0.3×	297 0.3×	354 1.2×	219 0.9×	49	1.3k
Wendy C. Bevier United States	23	1.2k 0.5×	828 0.6×	558 0.5×	34 0.1×	220 0.9×	65	1.8k
Charlotte K. Boughton United Kingdom	21	1.0k 0.4×	684 0.5×	593 0.5×	47 0.2×	56 0.2×	59	1.3k
Christine Darwin United States	21	871 0.4×	551 0.4×	365 0.3×	33 0.1×	234 0.9×	36	1.8k
H. Tillil United States	18	1.0k 0.4×	734 0.5×	450 0.4×	283 0.9×	417 1.6×	27	1.8k
B. V. Howard United States	21	872 0.4×	501 0.4×	116 0.1×	417 1.4×	1.1k 4.1×	34	2.6k
Hiroki Kishikawa Japan	21	748 0.3×	358 0.3×	173 0.1×	40 0.1×	216 0.8×	143	2.0k
George D. Molnar United States	21	1.7k 0.7×	781 0.6×	608 0.5×	67 0.2×	331 1.3×	62	2.2k
Jordan E. Pinsker United States	22	1.1k 0.5×	727 0.5×	658 0.6×	14 0.0×	49 0.2×	80	1.4k

Countries citing papers authored by Stacey M. Anderson

Since Specialization

Citations

This map shows the geographic impact of Stacey M. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey M. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey M. Anderson more than expected).

Fields of papers citing papers by Stacey M. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey M. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey M. Anderson. The network helps show where Stacey M. Anderson may publish in the future.

Co-authorship network of co-authors of Stacey M. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey M. Anderson. A scholar is included among the top collaborators of Stacey M. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey M. Anderson. Stacey M. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Stacey M., Lisa Norlander, Grenye O’Malley, et al.. (2021). Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study. Diabetes Care. 45(1). 186–193. 26 indexed citations

Schoelwer, Melissa J., J. Robic, Chiara Fabris, et al.. (2020). Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes. Diabetes Technology & Therapeutics. 22(8). 594–601. 18 indexed citations

Kovatchev, Boris, Laura Kollar, Stacey M. Anderson, et al.. (2020). Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial. The Lancet Digital Health. 2(2). e64–e73. 27 indexed citations

Anderson, Stacey M., Bruce A. Buckingham, Marc D. Breton, et al.. (2019). Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. Diabetes Technology & Therapeutics. 21(6). 356–363. 46 indexed citations

Breton, Marc D., Stephen D. Patek, Dayu Lv, et al.. (2018). Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus. Diabetes Technology & Therapeutics. 20(8). 531–540. 70 indexed citations

Brown, Sue A., Boris Kovatchev, Marc D. Breton, et al.. (2015). Multinight “Bedside” Closed-Loop Control for Patients with Type 1 Diabetes. Diabetes Technology & Therapeutics. 17(3). 203–209. 39 indexed citations

Breton, Marc D., et al.. (2014). Adding Heart Rate Signal to a Control-to-Range Artificial Pancreas System Improves the Protection Against Hypoglycemia During Exercise in Type 1 Diabetes. Diabetes Technology & Therapeutics. 16(8). 506–511. 103 indexed citations

Farhy, Leon S., Alice Chan, Marc D. Breton, et al.. (2012). Association of Basal Hyperglucagonemia with Impaired Glucagon Counterregulation in Type 1 Diabetes. Frontiers in Physiology. 3. 40–40. 6 indexed citations

Chan, Alice, et al.. (2011). Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus. Diabetologia. 55(3). 729–736. 9 indexed citations

10.

Kovatchev, Boris, et al.. (2011). Effect of Automated Bio-Behavioral Feedback on the Control of Type 1 Diabetes. Diabetes Care. 34(2). 302–307. 13 indexed citations

11.

Campbell, Laura K., Linda Gonder‐Frederick, Donna K. Broshek, et al.. (2010). Neurocognitive differences between drivers with type 1 diabetes with and without a recent history of recurrent driving mishaps. PubMed. 2(2). 73–77. 17 indexed citations

12.

Pitsillides, Achilleas, Stacey M. Anderson, & Boris Kovatchev. (2010). Hypoglycemia Risk and Glucose Variability Indices Derived from Routine Self-Monitoring of Blood Glucose Are Related to Laboratory Measures of Insulin Sensitivity and Epinephrine Counterregulation. Diabetes Technology & Therapeutics. 13(1). 11–17. 15 indexed citations

13.

Kovatchev, Boris, Stacey M. Anderson, Lutz Heinemann, & William L. Clarke. (2008). Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors. Diabetes Care. 31(10). e81–e81. 7 indexed citations

14.

Veldhuis, Johannes D., Stacey M. Anderson, Ali Iranmanesh, & Cyril Y. Bowers. (2005). Testosterone Blunts Feedback Inhibition of Growth Hormone Secretion by Experimentally Elevated Insulin-Like Growth Factor-I Concentrations. The Journal of Clinical Endocrinology & Metabolism. 90(3). 1613–1617. 23 indexed citations

15.

Veldhuis, Johannes D., Stacey M. Anderson, Petra Kok, et al.. (2004). Estradiol Supplementation Modulates Growth Hormone (GH) Secretory-Burst Waveform and Recombinant Human Insulin-Like Growth Factor-I-Enforced Suppression of Endogenously Driven GH Release in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 89(3). 1312–1318. 33 indexed citations

16.

Veldhuis, Johannes D., Stacey M. Anderson, N. Shah, et al.. (2001). Neurophysiological regulation andtarget-tissue impact of the pulsatile mode of growth hormone secretion in the human. Growth Hormone & IGF Research. 11. S25–S37. 55 indexed citations

17.

Evans, William S., et al.. (2001). Continuous 24-Hour Intravenous Infusion of Recombinant Human Growth Hormone (GH)-Releasing Hormone-(1–44)-Amide Augments Pulsatile, Entropic, and Daily Rhythmic GH Secretion in Postmenopausal Women Equally in the Estrogen-Withdrawn and Estrogen-Supplemented States¹. The Journal of Clinical Endocrinology & Metabolism. 86(2). 700–712. 37 indexed citations

18.

Veldhuis, Johannes D., William S. Evans, Cyril Y. Bowers, & Stacey M. Anderson. (2001). Interactive Regulation of Postmenopausal Growth Hormone Insulin-Like Growth Factor Axis by Estrogen and Growth Hormone-Releasing Peptide-2. Endocrine. 14(1). 45–62. 18 indexed citations

19.

Veldhuis, Johannes D., Martin Bidlingmaier, Stacey M. Anderson, Z. Wu, & C. J. Strasburger. (2001). Lowering Total Plasma Insulin-Like Growth Factor I Concentrations by Way of a Novel, Potent, and Selective Growth Hormone (GH) Receptor Antagonist, Pegvisomant (B2036-Peg), Augments the Amplitude of GH Secretory Bursts and Elevates Basal/Nonpulsatile GH Release in Healthy Women and Men¹. The Journal of Clinical Endocrinology & Metabolism. 86(7). 3304–3310. 63 indexed citations

20.

Nass, Ralf, Stacey M. Anderson, Bruce D. Gaylinn, et al.. (2000). High Plasma Growth Hormone (GH) Levels Inhibit Expression of GH Secretagogue Receptor Messenger Ribonucleic Acid Levels in the Rat Pituitary*. Endocrinology. 141(6). 2084–2089. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact